Depression affects about 5.8% of the Brazilian population and presents a wide range of symptoms, intensities, and durations.
The FDA still requires convincing safety and efficacy data on psychedelic agents, including MDMA, before approval. The VA and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results